Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02383472 · ClinicalTrials.gov registry record · NA

LED Therapy for the Treatment of Concussive Brain Injury

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT02383472 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02383472, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

A double blind randomized trial of light-emitting diode (LED) therapy for patients suffering from mild traumatic brain injury (mTBI). Patients seen in the Sports Concussion Clinic with cognitive symptoms lasting for greater than 4 weeks will be randomized to either placebo therapy (controls) or treatment with LED therapy (cases). Both cases and controls would complete post-concussion symptom scales Delis-Kaplan Executive Function System (D-KEFS), and ImPACT studies on entry into the study and at weeks 3 and 6, or earlier if their symptoms resolve before the end of the 6 week period.

Interventions

  • DEVICE MedX Health Console model 1100
  • DEVICE MedX Health Console model 1100-placebo

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2012-09
Est. Completion 2016-05
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02383472

The ClinicalTrials.gov registry entry for NCT02383472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which MedX Health Console model 1100 is the first listed.

NCT02383472 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02383472 about?

NCT02383472 is a clinical study titled "LED Therapy for the Treatment of Concussive Brain Injury". A double blind randomized trial of light-emitting diode (LED) therapy for patients suffering from mild traumatic brain injury (mTBI). Patients seen in the Sports Concussion Clinic with cognitive symptoms lasting for greater than 4 weeks will be randomized to either placebo therapy (controls) or trea...

What is the current status of trial NCT02383472?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2012-09. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02383472?

The interventions under investigation include: MedX Health Console model 1100 (DEVICE), MedX Health Console model 1100-placebo (DEVICE).

Who is sponsoring clinical trial NCT02383472?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.